BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

ConcertAI

ConcertAI logo

Founded
2017
Patents
1
Publications
38

Technologies

AI Companies (Drug Discovery)

ConcertAI is a developer of medical research tool suite intended to design and deliver care-based oncology research and data analytics. It is an integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients.

Posts Mentioning This Company

ConcertAI Unveils Next-Generation Clinical Trial Optimization Platform, CTO 2.0

  
ConcertAI, an AI Software-as-a-Service (SaaS) and Real-World Evidence (RWE) solutions provider for the life sciences and healthcare sectors, recently announced the launch of its Clinical Trial Optimization (CTO 2.0) platform. The new platform aims to address critical imperatives for trial sponsors, such as ensuring diverse representation of patient populations, meeting productivity …

8 Notable AI Companies in Clinical Research to Watch in 2022

  
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% for drug candidates moving from Phase 1 towards approval. Even if the drug candidate is safe and efficacious, clinical trials might fail due to the lack of financing, insufficient enrollment, …
SHARE